138 related articles for article (PubMed ID: 34755433)
1. Relapsed ANCA associated vasculitis following Oxford AstraZeneca ChAdOx1-S COVID-19 vaccination: A case series of two patients.
David R; Hanna P; Lee K; Ritchie A
Nephrology (Carlton); 2022 Jan; 27(1):109-110. PubMed ID: 34755433
[No Abstract] [Full Text] [Related]
2. Cutaneous Lymphocytic Vasculitis After Administration of the Second Dose of AZD1222 (Oxford-AstraZeneca) Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Casuality or Causality?
Ungari M; Pezzarossa E
Am J Dermatopathol; 2022 Jan; 44(1):80-82. PubMed ID: 34726187
[No Abstract] [Full Text] [Related]
3. Generalized bullous fixed drug eruption after Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccination.
Wantavornprasert K; Noppakun N; Klaewsongkram J; Rerknimitr P
Clin Exp Dermatol; 2022 Feb; 47(2):428-432. PubMed ID: 34482558
[No Abstract] [Full Text] [Related]
4. Symmetrical drug-related intertriginous and flexural exanthema like eruption associated with COVID-19 vaccination.
Lim PN; Wylie G
Clin Exp Dermatol; 2022 Jan; 47(1):175-176. PubMed ID: 34399001
[TBL] [Abstract][Full Text] [Related]
5. A case of ANCA-associated vasculitis after AZD1222 (Oxford-AstraZeneca) SARS-CoV-2 vaccination: casualty or causality?
Villa M; Díaz-Crespo F; Pérez de José A; Verdalles Ú; Verde E; Almeida Ruiz F; Acosta A; Mijaylova A; Goicoechea M
Kidney Int; 2021 Oct; 100(4):937-938. PubMed ID: 34416184
[No Abstract] [Full Text] [Related]
6. Report of two cases of minimal change disease following vaccination for COVID -19.
Baskaran K; Cohen AWS; Weerasinghe N; Vilayur E
Nephrology (Carlton); 2022 Jan; 27(1):111-112. PubMed ID: 34779088
[No Abstract] [Full Text] [Related]
7. A case of interstitial lung disease following Oxford-AstraZeneca COVID-19 vaccination.
Taverner JVB; Robertson JG
Intern Med J; 2022 Jul; 52(7):1276-1277. PubMed ID: 35879232
[No Abstract] [Full Text] [Related]
8. Cutaneous thrombosis associated with skin necrosis following Oxford-AstraZeneca COVID-19 vaccination.
Ramessur R; Saffar N; Czako B; Agarwal A; Batta K
Clin Exp Dermatol; 2021 Dec; 46(8):1610-1612. PubMed ID: 34189756
[No Abstract] [Full Text] [Related]
9. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.
Jarius S; Bieber N; Haas J; Wildemann B
J Neurol; 2022 Oct; 269(10):5198-5212. PubMed ID: 35737110
[TBL] [Abstract][Full Text] [Related]
10. Disseminated and localised herpes zoster following Oxford-AstraZeneca COVID-19 vaccination.
Jiang ZH; Wong LS; Lee CH; Hsu TJ; Yu YH
Indian J Dermatol Venereol Leprol; 2022; 88(3):445. PubMed ID: 35389012
[No Abstract] [Full Text] [Related]
11. De novo generalized pustular psoriasis following Oxford-AstraZeneca COVID-19 vaccine.
Elamin S; Hinds F; Tolland J
Clin Exp Dermatol; 2022 Jan; 47(1):153-155. PubMed ID: 34398977
[TBL] [Abstract][Full Text] [Related]
12. Unusual Site of Deep Vein Thrombosis After mRNA Coronavirus Disease-2019 (COVID-19) Vaccination.
Hasegawa T; Yazaki Y
Circ J; 2022 Mar; 86(4):723. PubMed ID: 34840204
[No Abstract] [Full Text] [Related]
13. Middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination.
Guan CY; Tsai SH; Fan JS; Lin YK; Kao CC
Am J Emerg Med; 2022 Jan; 51():427.e3-427.e4. PubMed ID: 34274191
[TBL] [Abstract][Full Text] [Related]
14. Isolated thrombosis after COVID-19 vaccination: case series.
Al-Ahmad M; Al Rasheed M; Altourah L; Rodriguez-Bouza T; Shalaby N
Int J Hematol; 2022 Feb; 115(2):153-157. PubMed ID: 34993889
[TBL] [Abstract][Full Text] [Related]
15. Case Report: Cytomegalovirus Reactivation and Pericarditis Following ChAdOx1 nCoV-19 Vaccination Against SARS-CoV-2.
Plüß M; Mese K; Kowallick JT; Schuster A; Tampe D; Tampe B
Front Immunol; 2021; 12():784145. PubMed ID: 35116025
[TBL] [Abstract][Full Text] [Related]
16. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
[TBL] [Abstract][Full Text] [Related]
17. Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature.
Gardellini A; Guidotti F; Maino E; Steffanoni S; Zancanella M; Turrini M
Blood Cells Mol Dis; 2021 Dec; 92():102615. PubMed ID: 34653943
[No Abstract] [Full Text] [Related]
18. Papilledema due to Vaccine-Induced Thrombocytopenia.
Qian J; Lutchman C; Margolin E
Ophthalmology; 2022 Feb; 129(2):190. PubMed ID: 35065733
[No Abstract] [Full Text] [Related]
19. A case of myocarditis following ChAdOx1 nCov-19 vaccination.
Van Kerkhove O; Renders F; Leys M
Acta Cardiol; 2022 Nov; 77(9):852-854. PubMed ID: 35189775
[No Abstract] [Full Text] [Related]
20. Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency.
Krzywicka K; Heldner MR; Sánchez van Kammen M; van Haaps T; Hiltunen S; Silvis SM; Levi M; Kremer Hovinga JA; Jood K; Lindgren E; Tatlisumak T; Putaala J; Aguiar de Sousa D; Middeldorp S; Arnold M; Coutinho JM; Ferro JM
Eur J Neurol; 2021 Nov; 28(11):3656-3662. PubMed ID: 34293217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
